Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats.
about
Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease.Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.A novel model for studying ileitis-induced visceral hypersensitivity in goats.The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats.Discovery and characterization of a novel tryptophan hydroxylase 1 inhibitor as a prodrug.Serum serotonin reduced the expression of hepatic transporter Mrp2 and P-gp via regulating nuclear receptor CAR in PI-IBS rats.Simultaneous Determination of Three Furanocoumarins by UPLC/MS/MS: Application to Pharmacokinetic Study of Angelica dahurica Radix after Oral Administration to Normal and Experimental Colitis-Induced Rats.Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome.The effect of chemically induced colitis, psychological stress and their combination on visceral pain in female Wistar rats.Halofuginone reduces the inflammatory responses of DSS-induced colitis through metabolic reprogramming.Electroacupuncture Relieves Visceral Hypersensitivity by Inactivating Protease-Activated Receptor 2 in a Rat Model of Postinfectious Irritable Bowel Syndrome
P2860
Q33578069-8D82B701-CA3B-4AB1-B785-ABAE25FC863FQ33618861-E50DEAEE-1E0B-4073-A664-D086CD24A100Q35336737-06293973-5AD3-42F4-B486-658E8D9299AFQ37315879-72DAAE7E-B0C7-48AF-9C01-841A6518705EQ37694194-EA14E474-2761-4BC0-BC0A-1FC702FC4433Q38674006-D1C00F63-0458-404F-83CF-EF3C1353C13DQ41176544-E703BB99-D096-462B-94E4-CE658D044985Q47955618-45FEC629-2A1A-42F7-9E12-C988F921F839Q50351674-204472C8-CE42-4BD6-A415-5EA9A00E966DQ51123173-A9105821-E78D-4E3B-AFA8-80E2BB3147E5Q53098030-72848DA3-6B20-45BF-A40F-7175E4B74B9EQ58699287-8E6AF56F-2743-4F6E-9653-0146F30D026A
P2860
Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Key factors in developing the ...... bowel syndrome model in rats.
@en
Key factors in developing the ...... bowel syndrome model in rats.
@nl
type
label
Key factors in developing the ...... bowel syndrome model in rats.
@en
Key factors in developing the ...... bowel syndrome model in rats.
@nl
prefLabel
Key factors in developing the ...... bowel syndrome model in rats.
@en
Key factors in developing the ...... bowel syndrome model in rats.
@nl
P2093
P2860
P356
P1476
Key factors in developing the ...... bowel syndrome model in rats.
@en
P2093
Brian M Berman
Hai-Tao Xiao
Hong-Yan Qin
Joseph J Y Sung
Justin C Y Wu
Zhao-Xiang Bian
P2860
P304
P356
10.3748/WJG.V18.I20.2481
P407
P577
2012-05-01T00:00:00Z